Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Changes in Stockholders??? Equity (Unaudited)

v3.21.2
Condensed Consolidated Statements of Changes in Stockholders’ Equity (Unaudited) - USD ($)
$ in Thousands
Common Stock
Additional Paid-in Capital
Accumulated Deficit
Total
Balance at Dec. 31, 2019 $ 2 $ 126,626 $ (42,172) $ 84,456
Balance (in Shares) at Dec. 31, 2019 22,862,835      
Exercise of stock options [1] 106 106
Exercise of stock options (in Shares) 57,325      
Stock-based compensation expenses   337   337
Net loss     (5,901) (5,901)
Balance at Mar. 31, 2020 $ 2 127,069 (48,073) 78,998
Balance (in Shares) at Mar. 31, 2020 22,920,160      
Exercise of stock options [1] 52 52
Exercise of stock options (in Shares) 220,104      
Stock-based compensation expenses 677 677
Net loss (6,206) (6,206)
Balance at Jun. 30, 2020 $ 2 127,798 (54,279) 73,521
Balance (in Shares) at Jun. 30, 2020 23,140,264      
Exercise of stock options [1] 38   38
Exercise of stock options (in Shares) 27,414      
Stock-based compensation expenses 1,114 1,114
Stock-based compensation expenses (in Shares)      
Net loss (8,835) (8,835)
Balance at Sep. 30, 2020 $ 2 128,950 (63,114) 65,838
Balance (in Shares) at Sep. 30, 2020 23,167,678      
Balance at Dec. 31, 2020 $ 2 129,725 (72,258) 57,469
Balance (in Shares) at Dec. 31, 2020 23,264,637      
Exercise of stock options [1] 23 23
Exercise of stock options (in Shares) 12,646      
Exercise of warrants [2]
Exercise of warrants (in Shares) 362,383      
Issuance of Common Stock under Open Market Sales Agreement [1] 4,334 4,334
Issuance of Common Stock under Open Market Sales Agreement (in Shares) 601,674      
Stock-based compensation expenses   530   530
Net loss     (8,402) (8,402)
Balance at Mar. 31, 2021 $ 2 134,612 (80,660) 53,954
Balance (in Shares) at Mar. 31, 2021 24,241,340      
Exercise of stock options [1] 78   78
Exercise of stock options (in Shares) 55,246      
Issuance of Common Stock under Open Market Sales Agreement [1] 801   801
Issuance of Common Stock under Open Market Sales Agreement (in Shares) 132,490      
Stock-based compensation expenses   1,095   1,095
Net loss     (7,336) (7,336)
Balance at Jun. 30, 2021 $ 2 136,586 (87,996) 48,592
Balance (in Shares) at Jun. 30, 2021 24,429,076      
Exercise of stock options [1] 20 20
Exercise of stock options (in Shares) 11,653      
Issuance of Common Stock under securities purchase agreement (“SPA”), net of $1,235 issuance costs [3] $ 1 13,765   13,766
Issuance of Common Stock under securities purchase agreement (“SPA”), net of $1,235 issuance costs (in Dollars per share) [3] $ 3,750,000      
Issuance of Common Stock under Open Market Sales Agreement [1] 53 53
Issuance of Common Stock under Open Market Sales Agreement (in Shares) 9,800      
Stock-based compensation expenses   1,027   1,027
Net loss     (10,031) (10,031)
Balance at Sep. 30, 2021 $ 3 $ 151,451 $ (98,027) $ 53,427
Balance (in Shares) at Sep. 30, 2021 28,200,529      
[1] Less than $1.
[2] See Note 5B.
[3] See Note 5A.